Health Care Select Sector SPDR Fund
Price through Oct 1 · Flows through Sep 30. Figures use the latest available records, not a live quote. Fund details retrieved Oct 1. Holdings snapshot retrieved Oct 1.
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
SOURCE: MARKET TAPE & DAILY CREATION/REDEMPTION RECORDS · 1M SHOWN · NET +$54M OVER THIS RANGE
Money keeps arriving — +$54M of net inflows over the past month, about 0.1% of the fund's asset base, while the price has returned +7.4% so far this year. At 0.090% a year, no lower reported fee appears among the alternatives shown here.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | LLYELI LILLY | 15.50% | $1149.85 | -0.6% | ||
| 2 | JNJJOHNSON & JOHNSON | 10.45% | $258.66 | -2.3% | ||
| 3 | ABBVABBVIE | 7.72% | $259.93 | -0.6% | ||
| 4 | MRKMERCK & CO | 5.44% | $143.81 | -1.0% | ||
| 5 | UNHUNITEDHEALTH GROUP | 6.49% | $365.20 | -0.5% | ||
| 6 | TMOTHERMO FISHER SCIENTIFIC | 3.64% | $652.51 | -3.3% | ||
| 7 | AMGNAMGEN | 3.55% | $407.27 | -3.4% | ||
| 8 | GILDGILEAD SCIENCES | 2.77% | $147.50 | -1.0% | ||
| 9 | ABTABBOTT LABORATORIES | 3.12% | $96.69 | -2.2% | ||
| 10 | PFEPFIZER | 2.41% | $28.12 | -1.4% | ||
| 11 | ISRGINTUITIVE SURGICAL | 2.12% | $401.24 | -1.3% | ||
| 12 | DHRDANAHER | 2.10% | $211.76 | -4.4% | ||
| 13 | VRTXVERTEX PHARMACEUTICALS | 2.07% | $506.74 | -3.1% | ||
| 14 | BMYBRISTOL MYERS SQUIBB | 2.25% | $61.46 | -1.5% | ||
| 15 | MDTMEDTRONIC | 1.87% | $86.44 | +0.2% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus CSV export, watchlists, and flow alerts — unlock across the network.
Sign in to see all 64| 1 week | -2.6% |
| 1 month | -3.2% |
| 3 months | +4.2% |
| 6 months | +15.6% |
| YTD | +7.4% |
| 1 year | +15.8% |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | +$204M |
| 1 month | +$54M |
| 3 months | +$299M |
| YTD | +$309M |
| 1 year | +$2.1B |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
The top holding is 15.5% of the book; the top ten carry 61%. Spread across 60+ names, it behaves like roughly 17 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| MRNA MODERNA | $35M | $34M |
| LLY ELI LILLY | $30M | $32M |
| UNH UNITEDHEALTH GROUP | $23M | $22M |
| MDT MEDTRONIC | $4M | $11M |
| HUM HUMANA | $8M | $7M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat XLV on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| SPDW State Street SPDR Portfolio Developed World ex-US ETF | 0.03% | $41.5B | +$286M | -6bp on fee · +$286M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.2B | +$199M | -6bp on fee · +$199M in over the month | Head-to-head |
| IDEV iShares Core MSCI International Developed Markets ETF | 0.04% | $32.9B | +$497M | -5bp on fee · +$497M in over the month | Head-to-head |
| IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF | 0.04% | $23.7B | +$575M | -5bp on fee · +$575M in over the month | Head-to-head |
| IGIB iShares 5-10 Year Investment Grade Corporate Bond ETF | 0.04% | $18.6B | +$412M | -5bp on fee · +$412M in over the month | Head-to-head |